beta-d-adenosine Report issue

Small molecule Experimental
AACT ChEMBL DrugBank Drug Central PubChem

Active Ingredient History

NOW
  • Now

Chemistry

  • SMILES: Nc1ncnc2c1ncn2[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O
  • InChIKey: OIRDTQYFTABQOQ-KQYNXXCUSA-N
  • Mol. Mass: 267.25
  • ALogP: -1.98
  • ChEMBL Molecule:
    adenosine  
More Chemistry

Pharmacology

  • Mechanisms of Action: Missing data
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Prescription Only
  • Delivery Methods: Parenteral
  • Pro Drug: No

Alternative names

(2r,3r,4s,5r)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol | 6-amino-9-beta-d-ribofuranosyl-9h-purine | 9-beta-d-ribofuranosidoadenine | 9-beta-d-ribofuranosyl-9h-purin-6-amine | adenin riboside | adenocard | adenocor | adenoscan | adenosin | adenosina | adenosine | adénosine | adenosinum | adenyldeoxyriboside | ade-rib | beta-d-adenosine | sr-96225

Organizations (2)

Research & Development (2)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Overview

  • Highest Phase: N/A
  • # of Trials: 1
  • # of Trial Organizations: 2

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue